Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications

por Unger, Jeffrey R., Parkin, Christopher G.
Publicado 2011

FRI653 Hemoglobin A1C-testing Inertia: A Barrier Observed In A Digital Diabetes Ecosystem Study

por Thingalaya, Nita, Kerr, David, Lee, Felix, Pantalone, Kevin M, Potukuchi, Praveen, Unger, Jeffrey, Grunberger, George
Publicado 2023

Achieving glycaemic control without weight gain, hypoglycaemia, or gastrointestinal adverse events in type 2 diabetes in the SUSTAIN clinical trial programme

por DeVries, J. Hans, Desouza, Cyrus, Bellary, Srikanth, Unger, Jeffrey, Hansen, Oluf K. H., Zacho, Jeppe, Woo, Vincent
Publicado 2018

A Pilot Study to Assess Clinical Utility and User Experience of Professional Continuous Glucose Monitoring Among People With Type 2 Diabetes

por Midyett, Kurt, Unger, Jeffrey R., Wright, Eugene E., Daniel, Timothy D., Kruger, Davida F., Henry, Robert R., Hegazi, Refaat A.
Publicado 2019

Use of an Automated Decision Support Tool Optimizes Clinicians’ Ability to Interpret and Appropriately Respond to Structured Self-Monitoring of Blood Glucose Data

por Rodbard, Helena W., Schnell, Oliver, Unger, Jeffrey, Rees, Christen, Amstutz, Linda, Parkin, Christopher G., Jelsovsky, Zhihong, Wegmann, Nathan, Axel-Schweitzer, Matthias, Wagner, Robin S.
Publicado 2012

Erratum. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and...

por Aroda, Vanita R., Rosenstock, Julio, Wysham, Carol, Unger, Jeffrey, Bellido, Diego, González-Gálvez, Guillermo, Takami, Akane, Guo, Hailing, Niemoeller, Elisabeth, Souhami, Elisabeth, Bergenstal, Richard M.
Publicado 2017